99% Savings - Buy Just @1 Rs X
Irbotan-150 is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Irbotan-150 safe for pregnant women?
Irbotan-150 shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Irbotan-150 safe during breastfeeding?
Irbotan-150 has been seen to have minimal side effects on breastfeeding women.
What is the effect of Irbotan-150 on the Kidneys?
Irbotan-150 is not harmful for kidneys.
What is the effect of Irbotan-150 on the Liver?
Using Irbotan-150 does not have any harmful effects on the liver.
What is the effect of Irbotan-150 on the Heart?
Irbotan-150 has very mild side effects on the heart.
Irbotan-150 should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Irbotan-150 unless your doctor advises you to do so -
Is this Irbotan-150 habit forming or addictive?
No, there is no any evidence that Irbotan-150 is addictive.
Interaction between Food and Irbotan-150
Eating certain foods may increase the time it takes Irbotan-150 to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Irbotan-150
No research has been done on this till date. Therefore, it is not known what the effect of taking Irbotan-150 with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avapro®* (irbesartan)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 506,507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173